TNFerade™ Plus Chemo/Radiation/Surgery for Rectal Cancer

Summary

The purpose of this study is to determine if the addition of TNFerade™ to pre-operative chemoradiotherapy increases the number of pathologic complete responses when compared to pre-operative chemoradiotherapy alone as assessed following complete surgical resection of primary rectal cancer.

Timeline

Start

—

Primary completion

—

Completion

—

Drugs

Indications